Alyeska Investment Group, L.P. Ars Pharmaceuticals, Inc. Comm Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 125,000 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.